MySerial AI
Anticipate the risk of medicine shortages by detecting early signs of supply pressure
MySerial AI enables MVOs to give authorities early visibility of medicines at risk of shortage in their country.
For each medicine, the solution combines serialisation data with data collected across Europe and worldwide. It also enables comparisons with other European countries to identify emerging supply pressures.
The analysis compares dispensing volumes against up to five years of historical data, while taking competing medicines and volumes placed on the market into account.
30 out of 33 shortages identified before they were officially reported by the authorities, in a retrospective analysis conducted in France.
The results
Signals detected up to 144 days before shortages were officially reported
30 out of 33
shortages
identified before official reporting, with at least two signals detected.
around
100 days
ahead of official reporting in the analysis conducted.
up to
144 days
ahead of official reporting when three signals were present.
These results come from a retrospective analysis conducted in France, comparing signals detected by MySerial AI with shortage reports from ANSM, the French medicines agency.
They measure the time gained before official reporting, rather than before the actual onset of a shortage. Performance may vary depending on the available data and national context.
Benefits for MVOs
Which medicines need your attention now?
An unusual change in volumes can be an early sign of supply pressure.
MySerial AI brings together several indicators to highlight situations that warrant closer analysis.
Spot unusual changes
Identify changes in serialisation and dispending data that may indicate a risk of shortage.
Focus your monitoring
Direct your teams' attention towards medicines for which several signals converge.
Support your analysis
Assess changes against historical patterns to understand the situations flagged and guide further investigation.
How it works
How MySerial AI detects shortage signals
1. Combine the available data
2. Analyse changes
3. Highlight situations for review
MySerial AI combines the serialisation data accessible to the MVO with complementary sources available in its country.
The solution calculates three indicators for each medicine to identify early signals. These include measuring the number of packs dispensed against a reference level drawn from the previous six months.
Combining these signals helps identify medicines potentially at risk of shortage and guides further analysis by MVO teams.
Data sources used in France
The work carried out in France draws on serialisation data from France MVO, reimbursement data from Ameli, the French national health insurance service, and medicine shortage information from ANSM.
For another countries, complementary sources and data access conditions need to be assessed with the MVO concerned.
MySerial AI for European MVOs
What MySerial AI could bring to your MVO
France provided the initial setting for MySerial AI's analysis, with access to serialisation data and complementary national sources. The first operational trials in France are now being prepared.
Design Data is now looking to explore this approach with other European MVOs.
Request a demo to see how the solution works, review the results obtained in France and discuss the data available in your country.
Request a demo for my MVO
Frequently Asked Questions
Your questions about MySerial AI
Discover MySerial AI for your MVO
Speak to Design Data about the results obtained in France and the potential for using the solution in your country.
Demos are available exclusively to MVO representatives.
Request your demo!
Request your demo